Please Wait.....
Report
Flexible Manufacturing Systems for Pharmaceutical Industry Market By Product Type (Modular manufacturing, Data-driven manufacturing, Single-use manufacturing, Continuous manufacturing), By Technology (Hardware, Software), By End User Industry (Large Pharmaceutical Manufacturers, Medium and Small Pharmaceutical Manufacturers): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-08-01 I 310 Pages I Allied Market Research
The global flexible manufacturing systems for pharmaceutical industry size was valued at $1,962.2 million in 2021 and is projected to reach $3,319.7 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.
A flexible manufacturing system for pharmaceuticals is a system that includes specialized machineries, processes, and operations involved in pharmaceutical manufacturing that are capable of being modified and changed within a short span of time to cope with sudden market changes.
Government and private agencies across the world keep a close eye on the pharmaceutical industry owing to its inherent nature of being associated with the lives of people and animals. Moreover, it is one of the few industries that is highly affected by politics across the world. Along with this, diseases evolve and often develop immunity to medicines. Such factors drive the demand for flexible manufacturing systems for pharmaceutical industry, as they allow quick response to market changes.
Increase in number of patients suffering from diseases such as heart diseases, diabetes, and arthritis rare diseases has significantly increased owing to rise in geriatric population. Furthermore, rise in number of patients has increased the demand for in pharmaceutical industry. These factors positively influence the growth of the flexible manufacturing systems for pharmaceutical industry. However, requirement for highly skilled professionals for operating and developing flexible manufacturing systems for pharmaceutical is a major restraint in the industry. Furthermore, rise in pharmaceutical industry in the emerging nations provides lucrative growth opportunities for the industry.
The global flexible manufacturing systems for pharmaceutical industry is segmented on the basis of type, technology, end user, and region. By type, the market is categorized into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing. On the basis of technology, it is segmented into software and hardware. By end user, it is bifurcated into large pharmaceutical manufacturers and medium & small pharmaceutical manufacturers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global market have adopted key strategies such as product launch, partnership, and acquisition to strengthen their market outreach and sustain the stiff competition in the market.
Competition Analysis
Key companies profiled in the flexible manufacturing systems for pharmaceutical industry report include Angstrom Technology, Biologics Modular, LLC, Chempharm, Cytiva, ESC (Environmental Systems Corporation), Exyte GmbH, G-CON Manufacturing, Germfree Laboratories Inc., IPM Technologies, KeyPlants Ab, ModuleCo Ltd., Modwave LLC, Nicomac Srl, NNE, Pharmadule Morimatsu AB, PR Pharma, and Engineers Pvt. Ltd.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flexible manufacturing systems for pharmaceutical industry market analysis from 2021 to 2031 to identify the prevailing flexible manufacturing systems for pharmaceutical industry market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the flexible manufacturing systems for pharmaceutical industry market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global flexible manufacturing systems for pharmaceutical industry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Modular manufacturing
- Data-driven manufacturing
- Single-use manufacturing
- Continuous manufacturing
By Technology
- Hardware
- Software
By End User Industry
- Large Pharmaceutical Manufacturers
- Method
- Machine Flexibility
- Volume Flexibility
- Medium and Small Pharmaceutical Manufacturers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Vietnam
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- UAE
- South Africa
- Kenya
- Key Market Players
- Angstrom Technology
- Biologics Modular, LLC
- Chempharm
- Cytiva
- ESC (Environmental Systems Corporation)
- Exyte GmbH
- G-CON Manufacturing
- Germfree Laboratories Inc.
- IPM Technologies
- KeyPlants Ab
- ModuleCo Ltd.
- Modwave LLC
- Nicomac Srl
- NNE
- Pharmadule Morimatsu AB
- PR Pharma Engineers Pvt. Ltd.
- Univercells Technologies
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Modular manufacturing
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Data-driven manufacturing
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Single-use manufacturing
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Continuous manufacturing
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Hardware
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Software
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY
6.1 Overview
6.1.1 Market size and forecast
6.2 Large Pharmaceutical Manufacturers
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
6.2.4.1 Machine Flexibility Market size and forecast, by region
6.2.4.2 Volume Flexibility Market size and forecast, by region
6.3 Medium and Small Pharmaceutical Manufacturers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End User Industry
7.2.4.1 North America Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End User Industry
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End User Industry
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End User Industry
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End User Industry
7.3.4.1 Europe Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End User Industry
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End User Industry
7.3.5.3 Italy
7.3.5.3.1 Market size and forecast, by Product Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End User Industry
7.3.5.4 UK
7.3.5.4.1 Market size and forecast, by Product Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End User Industry
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End User Industry
7.3.5.6 Netherlands
7.3.5.6.1 Market size and forecast, by Product Type
7.3.5.6.2 Market size and forecast, by Technology
7.3.5.6.3 Market size and forecast, by End User Industry
7.3.5.7 Rest of Europe
7.3.5.7.1 Market size and forecast, by Product Type
7.3.5.7.2 Market size and forecast, by Technology
7.3.5.7.3 Market size and forecast, by End User Industry
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End User Industry
7.4.4.1 Asia-Pacific Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End User Industry
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End User Industry
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End User Industry
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Product Type
7.4.5.4.2 Market size and forecast, by Technology
7.4.5.4.3 Market size and forecast, by End User Industry
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Product Type
7.4.5.5.2 Market size and forecast, by Technology
7.4.5.5.3 Market size and forecast, by End User Industry
7.4.5.6 Indonesia
7.4.5.6.1 Market size and forecast, by Product Type
7.4.5.6.2 Market size and forecast, by Technology
7.4.5.6.3 Market size and forecast, by End User Industry
7.4.5.7 Vietnam
7.4.5.7.1 Market size and forecast, by Product Type
7.4.5.7.2 Market size and forecast, by Technology
7.4.5.7.3 Market size and forecast, by End User Industry
7.4.5.8 Rest of Asia-Pacific
7.4.5.8.1 Market size and forecast, by Product Type
7.4.5.8.2 Market size and forecast, by Technology
7.4.5.8.3 Market size and forecast, by End User Industry
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End User Industry
7.5.4.1 LAMEA Large Pharmaceutical Manufacturers Flexible Manufacturing Systems for Pharmaceutical Industry Market by Method
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End User Industry
7.5.5.2 Argentina
7.5.5.2.1 Market size and forecast, by Product Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End User Industry
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Product Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End User Industry
7.5.5.4 UAE
7.5.5.4.1 Market size and forecast, by Product Type
7.5.5.4.2 Market size and forecast, by Technology
7.5.5.4.3 Market size and forecast, by End User Industry
7.5.5.5 South Africa
7.5.5.5.1 Market size and forecast, by Product Type
7.5.5.5.2 Market size and forecast, by Technology
7.5.5.5.3 Market size and forecast, by End User Industry
7.5.5.6 Kenya
7.5.5.6.1 Market size and forecast, by Product Type
7.5.5.6.2 Market size and forecast, by Technology
7.5.5.6.3 Market size and forecast, by End User Industry
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Angstrom Technology
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Biologics Modular, LLC
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Chempharm
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cytiva
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 ESC (Environmental Systems Corporation)
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Exyte GmbH
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 G-CON Manufacturing
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Germfree Laboratories Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 IPM Technologies
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 KeyPlants Ab
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 ModuleCo Ltd.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Modwave LLC
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Nicomac Srl
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 NNE
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Pharmadule Morimatsu AB
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 PR Pharma Engineers Pvt. Ltd.
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Univercells Technologies
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 2. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR MODULAR MANUFACTURING, BY REGION, 2021-2031 ($MILLION)
TABLE 3. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR MODULAR MANUFACTURING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR DATA-DRIVEN MANUFACTURING, BY REGION, 2021-2031 ($MILLION)
TABLE 5. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR DATA-DRIVEN MANUFACTURING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR SINGLE-USE MANUFACTURING, BY REGION, 2021-2031 ($MILLION)
TABLE 7. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR SINGLE-USE MANUFACTURING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR CONTINUOUS MANUFACTURING, BY REGION, 2021-2031 ($MILLION)
TABLE 9. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR CONTINUOUS MANUFACTURING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. GLOBAL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 11. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 12. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR HARDWARE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 14. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR SOFTWARE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. GLOBAL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 16. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR LARGE PHARMACEUTICAL MANUFACTURERS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR LARGE PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL LARGE PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 19. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR MACHINE FLEXIBILITY, BY REGION, 2021-2031 ($MILLION)
TABLE 20. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR VOLUME FLEXIBILITY, BY REGION, 2021-2031 ($MILLION)
TABLE 21. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, FOR MEDIUM AND SMALL PHARMACEUTICAL MANUFACTURERS, BY REGION, 2021-2031 ($MILLION)
TABLE 22. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET FOR MEDIUM AND SMALL PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 24. NORTH AMERICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA LARGE PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. U.S. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 30. U.S. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 31. U.S. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 32. CANADA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 33. CANADA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 34. CANADA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 35. MEXICO FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 36. MEXICO FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 37. MEXICO FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 38. EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 39. EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 40. EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 41. EUROPE LARGE PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 42. EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 43. GERMANY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 44. GERMANY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 45. GERMANY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 46. FRANCE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 47. FRANCE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 48. FRANCE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 49. ITALY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 50. ITALY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 51. ITALY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 52. UK FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 53. UK FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 54. UK FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 55. SPAIN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 56. SPAIN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 57. SPAIN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 58. NETHERLANDS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 59. NETHERLANDS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 60. NETHERLANDS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC LARGE PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. CHINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 70. CHINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 71. CHINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 72. JAPAN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 73. JAPAN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 74. JAPAN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 75. INDIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 76. INDIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 77. INDIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 78. SOUTH KOREA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 79. SOUTH KOREA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 80. SOUTH KOREA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 81. AUSTRALIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 82. AUSTRALIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 83. AUSTRALIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 84. INDONESIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 85. INDONESIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 86. INDONESIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 87. VIETNAM FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 88. VIETNAM FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 89. VIETNAM FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 93. LAMEA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 94. LAMEA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 95. LAMEA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 96. LAMEA LARGE PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY METHOD, 2021-2031 ($MILLION)
TABLE 97. LAMEA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 98. BRAZIL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 99. BRAZIL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 100. BRAZIL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 101. ARGENTINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 102. ARGENTINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 103. ARGENTINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 104. SAUDI ARABIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 105. SAUDI ARABIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 106. SAUDI ARABIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 107. UAE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 108. UAE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 109. UAE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 110. SOUTH AFRICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 111. SOUTH AFRICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 112. SOUTH AFRICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 113. KENYA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
TABLE 114. KENYA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY TECHNOLOGY, 2021-2031 ($MILLION)
TABLE 115. KENYA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET, BY END USER INDUSTRY, 2021-2031 ($MILLION)
TABLE 116.ANGSTROM TECHNOLOGY: COMPANY SNAPSHOT
TABLE 117.ANGSTROM TECHNOLOGY: OPERATING SEGMENTS
TABLE 118.ANGSTROM TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 119.ANGSTROM TECHNOLOGY: NET SALES,
TABLE 120.ANGSTROM TECHNOLOGY: KEY STRATERGIES
TABLE 121.BIOLOGICS MODULAR, LLC: COMPANY SNAPSHOT
TABLE 122.BIOLOGICS MODULAR, LLC: OPERATING SEGMENTS
TABLE 123.BIOLOGICS MODULAR, LLC: PRODUCT PORTFOLIO
TABLE 124.BIOLOGICS MODULAR, LLC: NET SALES,
TABLE 125.BIOLOGICS MODULAR, LLC: KEY STRATERGIES
TABLE 126.CHEMPHARM: COMPANY SNAPSHOT
TABLE 127.CHEMPHARM: OPERATING SEGMENTS
TABLE 128.CHEMPHARM: PRODUCT PORTFOLIO
TABLE 129.CHEMPHARM: NET SALES,
TABLE 130.CHEMPHARM: KEY STRATERGIES
TABLE 131.CYTIVA: COMPANY SNAPSHOT
TABLE 132.CYTIVA: OPERATING SEGMENTS
TABLE 133.CYTIVA: PRODUCT PORTFOLIO
TABLE 134.CYTIVA: NET SALES,
TABLE 135.CYTIVA: KEY STRATERGIES
TABLE 136.ESC (ENVIRONMENTAL SYSTEMS CORPORATION): COMPANY SNAPSHOT
TABLE 137.ESC (ENVIRONMENTAL SYSTEMS CORPORATION): OPERATING SEGMENTS
TABLE 138.ESC (ENVIRONMENTAL SYSTEMS CORPORATION): PRODUCT PORTFOLIO
TABLE 139.ESC (ENVIRONMENTAL SYSTEMS CORPORATION): NET SALES,
TABLE 140.ESC (ENVIRONMENTAL SYSTEMS CORPORATION): KEY STRATERGIES
TABLE 141.EXYTE GMBH: COMPANY SNAPSHOT
TABLE 142.EXYTE GMBH: OPERATING SEGMENTS
TABLE 143.EXYTE GMBH: PRODUCT PORTFOLIO
TABLE 144.EXYTE GMBH: NET SALES,
TABLE 145.EXYTE GMBH: KEY STRATERGIES
TABLE 146.G-CON MANUFACTURING: COMPANY SNAPSHOT
TABLE 147.G-CON MANUFACTURING: OPERATING SEGMENTS
TABLE 148.G-CON MANUFACTURING: PRODUCT PORTFOLIO
TABLE 149.G-CON MANUFACTURING: NET SALES,
TABLE 150.G-CON MANUFACTURING: KEY STRATERGIES
TABLE 151.GERMFREE LABORATORIES INC.: COMPANY SNAPSHOT
TABLE 152.GERMFREE LABORATORIES INC.: OPERATING SEGMENTS
TABLE 153.GERMFREE LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 154.GERMFREE LABORATORIES INC.: NET SALES,
TABLE 155.GERMFREE LABORATORIES INC.: KEY STRATERGIES
TABLE 156.IPM TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 157.IPM TECHNOLOGIES: OPERATING SEGMENTS
TABLE 158.IPM TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 159.IPM TECHNOLOGIES: NET SALES,
TABLE 160.IPM TECHNOLOGIES: KEY STRATERGIES
TABLE 161.KEYPLANTS AB: COMPANY SNAPSHOT
TABLE 162.KEYPLANTS AB: OPERATING SEGMENTS
TABLE 163.KEYPLANTS AB: PRODUCT PORTFOLIO
TABLE 164.KEYPLANTS AB: NET SALES,
TABLE 165.KEYPLANTS AB: KEY STRATERGIES
TABLE 166.MODULECO LTD.: COMPANY SNAPSHOT
TABLE 167.MODULECO LTD.: OPERATING SEGMENTS
TABLE 168.MODULECO LTD.: PRODUCT PORTFOLIO
TABLE 169.MODULECO LTD.: NET SALES,
TABLE 170.MODULECO LTD.: KEY STRATERGIES
TABLE 171.MODWAVE LLC: COMPANY SNAPSHOT
TABLE 172.MODWAVE LLC: OPERATING SEGMENTS
TABLE 173.MODWAVE LLC: PRODUCT PORTFOLIO
TABLE 174.MODWAVE LLC: NET SALES,
TABLE 175.MODWAVE LLC: KEY STRATERGIES
TABLE 176.NICOMAC SRL: COMPANY SNAPSHOT
TABLE 177.NICOMAC SRL: OPERATING SEGMENTS
TABLE 178.NICOMAC SRL: PRODUCT PORTFOLIO
TABLE 179.NICOMAC SRL: NET SALES,
TABLE 180.NICOMAC SRL: KEY STRATERGIES
TABLE 181.NNE: COMPANY SNAPSHOT
TABLE 182.NNE: OPERATING SEGMENTS
TABLE 183.NNE: PRODUCT PORTFOLIO
TABLE 184.NNE: NET SALES,
TABLE 185.NNE: KEY STRATERGIES
TABLE 186.PHARMADULE MORIMATSU AB: COMPANY SNAPSHOT
TABLE 187.PHARMADULE MORIMATSU AB: OPERATING SEGMENTS
TABLE 188.PHARMADULE MORIMATSU AB: PRODUCT PORTFOLIO
TABLE 189.PHARMADULE MORIMATSU AB: NET SALES,
TABLE 190.PHARMADULE MORIMATSU AB: KEY STRATERGIES
TABLE 191.PR PHARMA ENGINEERS PVT. LTD.: COMPANY SNAPSHOT
TABLE 192.PR PHARMA ENGINEERS PVT. LTD.: OPERATING SEGMENTS
TABLE 193.PR PHARMA ENGINEERS PVT. LTD.: PRODUCT PORTFOLIO
TABLE 194.PR PHARMA ENGINEERS PVT. LTD.: NET SALES,
TABLE 195.PR PHARMA ENGINEERS PVT. LTD.: KEY STRATERGIES
TABLE 196.UNIVERCELLS TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 197.UNIVERCELLS TECHNOLOGIES: OPERATING SEGMENTS
TABLE 198.UNIVERCELLS TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 199.UNIVERCELLS TECHNOLOGIES: NET SALES,
TABLE 200.UNIVERCELLS TECHNOLOGIES: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET SEGMENTATION
FIGURE 2.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031
FIGURE 3.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,BY PRODUCT TYPE,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF MODULAR MANUFACTURING FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DATA-DRIVEN MANUFACTURING FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SINGLE-USE MANUFACTURING FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CONTINUOUS MANUFACTURING FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 17.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,BY TECHNOLOGY,2021(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HARDWARE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SOFTWARE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 20.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,BY END USER INDUSTRY,2021(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF LARGE PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MEDIUM AND SMALL PHARMACEUTICAL MANUFACTURERS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031(%)
FIGURE 23.FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET BY REGION,2021
FIGURE 24.U.S. FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 25.CANADA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 26.MEXICO FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 27.GERMANY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 28.FRANCE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 29.ITALY FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 30.UK FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 31.SPAIN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 32.NETHERLANDS FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 33.REST OF EUROPE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 34.CHINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 35.JAPAN FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 36.INDIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 37.SOUTH KOREA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 38.AUSTRALIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 39.INDONESIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 40.VIETNAM FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 41.REST OF ASIA-PACIFIC FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 42.BRAZIL FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 43.ARGENTINA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 44.SAUDI ARABIA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 45.UAE FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 46.SOUTH AFRICA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 47.KENYA FLEXIBLE MANUFACTURING SYSTEMS FOR PHARMACEUTICAL INDUSTRY MARKET,2021-2031($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52.COMPETITIVE DASHBOARD
FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 54.ANGSTROM TECHNOLOGY.: NET SALES ,($MILLION)
FIGURE 55.BIOLOGICS MODULAR, LLC.: NET SALES ,($MILLION)
FIGURE 56.CHEMPHARM.: NET SALES ,($MILLION)
FIGURE 57.CYTIVA.: NET SALES ,($MILLION)
FIGURE 58.ESC (ENVIRONMENTAL SYSTEMS CORPORATION).: NET SALES ,($MILLION)
FIGURE 59.EXYTE GMBH.: NET SALES ,($MILLION)
FIGURE 60.G-CON MANUFACTURING.: NET SALES ,($MILLION)
FIGURE 61.GERMFREE LABORATORIES INC..: NET SALES ,($MILLION)
FIGURE 62.IPM TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 63.KEYPLANTS AB.: NET SALES ,($MILLION)
FIGURE 64.MODULECO LTD..: NET SALES ,($MILLION)
FIGURE 65.MODWAVE LLC.: NET SALES ,($MILLION)
FIGURE 66.NICOMAC SRL.: NET SALES ,($MILLION)
FIGURE 67.NNE.: NET SALES ,($MILLION)
FIGURE 68.PHARMADULE MORIMATSU AB.: NET SALES ,($MILLION)
FIGURE 69.PR PHARMA ENGINEERS PVT. LTD..: NET SALES ,($MILLION)
FIGURE 70.UNIVERCELLS TECHNOLOGIES.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security